4//SEC Filing
Rowinsky Eric K 4
Accession 0001104659-24-000899
CIK 0001429260other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:47 PM ET
Size
5.9 KB
Accession
0001104659-24-000899
Insider Transaction Report
Form 4
Rowinsky Eric K
DirectorVice Chairman of the Board
Transactions
- Award
COMMON STOCK, PAR VALUE $0.001
2024-01-01+6,666→ 68,797 total
Footnotes (3)
- [F1]Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
- [F2]One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer.
- [F3]Total holdings include 19,998 shares underlying deferred restricted stock units.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001318886
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:47 PM ET
- Size
- 5.9 KB